EGFR and cancer: For instance, mutations of Epidermal Growth Factor Receptor, EGFR/PI3K, loss of the tumor suppressor protein phosphatase and tensin homologue (PTEN), and mutations or amplifications of Akt itself enhance Akt’s signaling in cancer cells [34,35].